These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15025261)

  • 1. Bioartificial liver support for fulminant hepatic failure.
    Anand AC
    Indian J Gastroenterol; 2003 Dec; 22 Suppl 2():S69-74. PubMed ID: 15025261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial liver support devices for fulminant liver failure.
    Sechser A; Osorio J; Freise C; Osorio RW
    Clin Liver Dis; 2001 May; 5(2):415-30. PubMed ID: 11385970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioartificial liver support.
    Hui T; Rozga J; Demetriou AA
    J Hepatobiliary Pancreat Surg; 2001; 8(1):1-15. PubMed ID: 11294283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical issues in bioartificial liver development.
    Tilles AW; Berthiaume F; Yarmush ML; Toner M
    Technol Health Care; 2002; 10(3-4):177-86. PubMed ID: 12118141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs.
    Li LJ; Du WB; Zhang YM; Li J; Pan XP; Chen JJ; Cao HC; Chen Y; Chen YM
    J Hepatol; 2006 Feb; 44(2):317-24. PubMed ID: 16356580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver support systems today].
    Rikker C
    Orv Hetil; 2009 Dec; 150(51):2299-307. PubMed ID: 19995693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of serum from rats with fulminant hepatic failure on hepatocytes in a bioartificial liver system.
    Ito Y; Eguchi S; Kamohara Y; Inuo H; Yamanouchi K; Okudaira S; Yanaga K; Furui J; Kanematsu T
    Int J Artif Organs; 2004 Apr; 27(4):303-10. PubMed ID: 15163064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact.
    Millis JM; Cronin DC; Johnson R; Conjeevaram H; Conlin C; Trevino S; Maguire P
    Transplantation; 2002 Dec; 74(12):1735-46. PubMed ID: 12499890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of an extracorporeal flat-plate bioartificial liver in treating fulminant hepatic failure.
    Shito M; Tilles AW; Tompkins RG; Yarmush ML; Toner M
    J Surg Res; 2003 May; 111(1):53-62. PubMed ID: 12842448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioartificial liver support. Review and personal experience.
    Ambrosino G; D'Amico DF
    Minerva Chir; 2003 Oct; 58(5):649-56. PubMed ID: 14603145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure.
    Kamohara Y; Fujioka H; Eguchi S; Kawashita Y; Furui J; Kanematsu T
    Artif Organs; 2000 Apr; 24(4):265-70. PubMed ID: 10816199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical translation of bioartificial liver support systems with human pluripotent stem cell-derived hepatic cells.
    Sakiyama R; Blau BJ; Miki T
    World J Gastroenterol; 2017 Mar; 23(11):1974-1979. PubMed ID: 28373763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The bioartificial liver: state-of-the-art.
    Dixit V; Gitnick G
    Eur J Surg Suppl; 1998; (582):71-6. PubMed ID: 10029369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats.
    Shinoda M; Tilles AW; Kobayashi N; Wakabayashi G; Takayanagi A; Totsugawa T; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Tanaka N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    J Surg Res; 2007 Jan; 137(1):130-40. PubMed ID: 17081566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A bioartificial liver--state of the art.
    Strain AJ; Neuberger JM
    Science; 2002 Feb; 295(5557):1005-9. PubMed ID: 11834813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioartificial liver treatment prolongs survival and lowers intracranial pressure in pigs with fulminant hepatic failure.
    Khalili TM; Navarro A; Ting P; Kamohara Y; Arkadopoulos N; Solomon BA; Demetriou AA; Rozga J
    Artif Organs; 2001 Jul; 25(7):566-70. PubMed ID: 11493278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist.
    Shinoda M; Tilles AW; Wakabayashi G; Takayanagi A; Harada H; Obara H; Suganuma K; Berthiaume F; Shimazu M; Shimizu N; Kitajima M; Tompkins RG; Toner M; Yarmush ML
    Tissue Eng; 2006 May; 12(5):1313-23. PubMed ID: 16771644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of human fulminant hepatic failure sera on endogenous retroviral expression in pig hepatocytes.
    Nyberg SL; Hibbs JR; Hardin JA; Germer JJ; Platt JL; Paya CV; Wiesner RH
    Liver Transpl; 2000 Jan; 6(1):76-84. PubMed ID: 10648582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress in bioreactors of bioartificial livers.
    Yu CB; Pan XP; Li LJ
    Hepatobiliary Pancreat Dis Int; 2009 Apr; 8(2):134-40. PubMed ID: 19357025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioartificial liver system based on choanoid fluidized bed bioreactor improve the survival time of fulminant hepatic failure pigs.
    Lv G; Zhao L; Zhang A; Du W; Chen Y; Yu C; Pan X; Zhang Y; Song T; Xu J; Chen Y; Li L
    Biotechnol Bioeng; 2011 Sep; 108(9):2229-36. PubMed ID: 21455934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.